AGP Executive Report
Last update: 11 hours agoBrain-Tech & Rehab: China approved the world’s first commercial brain-computer chip, the NEO, for spinal cord injury and paralysis, with mass production planned for the state health system—positioning it ahead of Neuralink’s still-pending FDA path. AI Infrastructure: Beijing is reportedly preparing a 2 trillion yuan, five-year push for a nationwide AI data-center network, relying heavily on domestic chips and suppliers—an explicit bid to reduce dependence on U.S. hardware. Regulator Watch: China’s market regulator summoned Walmart China/Sam’s Club executives over repeated food safety problems, demanding tighter controls across the supply chain and online sales. Clinical Research (China): A real-world Chinese study on posaconazole in invasive pulmonary fungal infection highlights concerns around subtherapeutic exposure and hepatotoxicity thresholds, reinforcing the case for therapeutic drug monitoring. Health & Aging (Research): A scoping review in BMC Geriatrics maps how Confucian norms shape sexual health perceptions among Chinese older adults, pointing to the need for culturally competent nursing care. Market Signals: Separate reports on green tea and diet quality link healthier patterns with lower heart disease/cancer risk and better metabolic aging markers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
